Novartis | NVS - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 444.6B 59.91B 2026-06
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bausch Health Companies USD 3.36B 754.42M 2026-10
Biogen USD 37.56B 4.18B 2026-10
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Canopy Growth CAD 557.13M 99.33M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 196.01B 39.15B 2026-10
GlaxoSmithKline GBP 76.75B 2.64B 2026-10
Glaxosmithkline GBP 109.29B 9.36B 2026-03
J&J USD 607B 46.61B 2026-10
Merck USD 317.37B 20.27B 2026-06
Novartis USD 266.01B 25.42B 2026-10
Novartis USD 288.26B 25.18B 2026-03
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.24B 566M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Supernus Pharmaceuticals USD 2.7B 277M 2026-06
Zoetis USD 30.13B 19.58B 2026-06